Metabo Drops Investigated: Is It Worth It in 2026? Truth Behind the Liquid Metabolism Drops

As metabolism supplements continue to grow in popularity in 2026, many consumers are seeking clear, factual information to ...

Telix Achieves FY 2025 Guidance with US$804M (A$1.2B) Revenue, Accelerates Growth with Gozellix Launch

Full-year (FY) 2025 unaudited Group revenue of approximately US$804 million (A$1.2 billion 1 ), in line with upgraded guidance of US$800-$820 million 2 (previously US$770-800 million). Q4 2025 ...
pharmaphorum

FDA turns down Regeneron bispecific blood cancer antibody

The FDA has turned down a pair of marketing applications for Regeneron’s CD20xCD3 bispecific antibody odronextamab to treat two common forms of non-Hodgkin lymphoma (NHL). The decision throws a ...
pharmaphorum

After FDA no, Regeneron gets yes from EU on odronextamab

Regeneron's CD20xCD3 bispecific antibody for non-Hodgin lymphoma (NHL) has been approved in Europe, five months after it was turned down by the FDA in the US. Ordspono (odronextamab) has been cleared ...
Prepared Foods

Kemin: Clean Label Solutions

Attendees are invited to visit booth #C27155 and meet with Kemin Food Technologies – North America experts to learn how the ...